Coherus BioSciences, Inc. 4
4 · Coherus BioSciences, Inc. · Filed Jul 25, 2016
Insider Transaction Report
Form 4
Watler Peter K.
Chief Technical Officer
Transactions
- Sale
Common Stock, $0.0001 par value
2016-07-21$26.05/sh−3,291$85,735→ 700 total - Sale
Common Stock, $0.0001 par value
2016-07-21$26.48/sh−700$18,537→ 0 total - Exercise/Conversion
Common Stock, $0.0001 par value
2016-07-21$2.08/sh+3,991$8,316→ 3,991 total - Exercise/Conversion
Stock Option (right to buy)
2016-07-21−3,991→ 88,503 totalExercise: $2.08Exp: 2022-12-13→ Common Stock (3,991 underlying)
Footnotes (4)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $25.41 to $26.39, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The transaction was executed in multiple trades in prices ranging from $26.42 to $26.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F4]All shares underlying this option are vested and exercisable as of the date hereof.